Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BALAXI PHARMA Fact Sheet  (BLPH)



Opportunity Alert: Stocks from India's Emerging Businesses


Here is the latest financial fact sheet of BALAXI PHARMA. For more details, see the BALAXI PHARMA quarterly results and BALAXI PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

BALAXI PHARMA Price History

Price Rs 554.8
Mkt Cap Rs m 5,676
Vol '000 25.3
P/E X 11.2
P/CF X 11.8
EPS (TTM) Rs 49.4
1 Day % -7.4
No. of shares m 10.23
1 Week % -13.1
1 Month % 4.2
1 Year % 34.2
52 week H/L Rs 706.0/303.6
As on May 30, 2023 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BALAXI PHARMA Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
12
Mar-22
*
5-Yr Chart
Click to enlarge
BALAXI PHARMA EQUITY SHARE DATA
High RsNANANANA702 
Low RsNANANANA342 
Sales per share (Unadj.) Rs044.745.6231.3279.4 
Earnings per share (Unadj.) Rs-2.56.56.138.147.7 
Diluted earnings per shareRs-0.81.96.037.346.6 
Cash flow per share (Unadj.) Rs-2.56.56.138.448.2 
Dividends per share (Unadj.) Rs00000.50 
Adj. dividends per shareRs0.000.000.000.000.49 
Avg Dividend yield %00000.1 
Book value per share (Unadj.) Rs5.111.627.765.0113.2 
Adj. book value per shareRs1.53.427.163.5110.6 
Shares outstanding (eoy) m3.043.0410.0010.0010.00 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x00001.9 
Avg P/E ratio x000010.9 
P/CF ratio (eoy) x000010.8 
Price / Book Value ratio x00004.6 
Dividend payout %00001.0 
Avg Mkt Cap Rs m00005,218 
No. of employees `000NANANANANA 
Total wages/salary Rs m292185125 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
BALAXI PHARMA INCOME DATA
Net Sales Rs m01364562,3132,794 
Other income Rs m0962250 
Total revenues Rs m01454622,3362,844 
Gross profit Rs m-81683427508 
Depreciation Rs m00035 
Interest Rs m00038 
Profit before tax Rs m-82488443545 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m05276269 
Profit after tax Rs m-82061381477 
Gross profit margin %011.518.118.418.2 
Effective tax rate %019.430.614.012.6 
Net profit margin %014.513.416.517.1 
BALAXI PHARMA BALANCE SHEET DATA
Current assets Rs m16583499381,410 
Current liabilities Rs m12682347633 
Net working cap to sales %023.558.425.527.8 
Current ratio x12.52.24.22.72.2 
Inventory Days Days09758 
Debtors Days Days0146,9642,3771,211374 
Net fixed assets Rs m031159355 
Share capital Rs m3030100100100 
"Free" reserves Rs m-1551775501,032 
Net worth Rs m16352776501,132 
Long term debt Rs m00000 
Total assets Rs m17613609971,765 
Interest coverage x01,221.0184.2160.572.6 
Debt to equity ratio x00000 
Sales to assets ratio x02.21.32.31.6 
Return on assets %-45.632.217.138.527.4 
Return on equity %-49.555.822.058.742.1 
Return on capital %-49.569.331.968.648.9 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m01364568691,000 
Fx outflow Rs m001011087 
Net fx Rs m0136447759913 
BALAXI PHARMA CASH FLOW
From Operations Rs m -7 -15 -140 0 341 
From Investments Rs m -0 -0 -2 -60 -284 
From Financial Activity Rs m 0 0 181 36 -2 
Net Cashflow Rs m -7 -15 39 -23 55 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 71.6%
Institution 18.7%
Non-Institution 9.8%
Total 100.0%
Free Float 28.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2023
 

Company Information

Regd Off Plot No.409 2rd Floor H No 8-2-293, Maps Towers Jubilee Hills, Road No:81, Hyderabad - 500096
E-mail info@balaxipharma.in Web www.balaxipharma.in
Tel 040 23555300 Fax
Sector TRADING Group Private sector
Tr Agent Aarthi Consultants Pvt Ltd, 1-2-285, Domalaguda
CHM: Ashish Maheshwari COMP SEC: Nidhin Jose YEAR OF INC: 1942 NSE CODE: 911309 FV (Rs): 10 DIV YIELD (%): 0.1

More Trading Company Fact Sheets:   AUROBINDO PHARMA    CIPLA    PIRAMAL ENTERPRISES    LUPIN    DR. REDDYS LAB    

Compare BALAXI PHARMA With:   AUROBINDO PHARMA    CIPLA    PIRAMAL ENTERPRISES    LUPIN    DR. REDDYS LAB    




Today's Market

Sensex Today Ends 123 Points Higher | HAL Gains 3% | ITC and HCL Tech Among Top Gainers Sensex Today Ends 123 Points Higher | HAL Gains 3% | ITC and HCL Tech Among Top Gainers(Closing)

After opening the day higher, Indian share markets continued their momentum as session progressed and ended higher for the fourth straight session.